Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2020 | AsclepiX Therapeutics | $35.0M Series A | Perceptive Advisors | Rapha Capital Management |
| Jun 17, 2019 | Viela Bio | $75.0M Series B | HBM Healthcare Investments | Cormorant Asset Management, Goldman Sachs, Temasek, Terra Magnum Capital Partners, Viking Global Investors |
| Nov 13, 2018 | AsclepiX Therapeutics | $5.0M Other Equity | Joshua Barer | Piedmont Capital Partners, Kevin Slawin, Salem Partners, TEDCO |